Preventing medication errors in cancer chemotherapy

Cohen, Michael R.; Anderson, Roger W.; Attilio, Richard M.; Green, Laurence; Muller, Raymond J.; Pruemer, Jane M.

doi:10.1093/ajhp/53.7.737

Cited by 109 publications

(107 citation statements)

References 0 publications

Supporting

Mentioning

106

Contrasting

Order By: Relevance

“…In 1996, the American Society of Health-System Pharmacists [20] proposed the following seven measures to prevent medication errors in cancer chemotherapy: educate healthcare providers, verify the dose, establish dosage limits, standardize the prescribing vocabulary, work with drug manufacturers, educate patients, and improve communication. In the past, verifying the dose, establishing dosage limits, and standardizing the prescribing vocabulary depended on healthcare personnel (physicians, pharmacists, and nurses) in preventing potential errors.…”

Section: Discussionmentioning

confidence: 99%

Applying HFMEA to Prevent Chemotherapy Errors

et al. 2010

View full text Add to dashboard Cite

To evaluate risk and vulnerability in the chemotherapy process using a proactive risk analysis method. Healthcare failure mode and effect analysis (HFMEA) was adopted to identify potential chemotherapy process failures. A multidisciplinary team is formed to identify, evaluate, and prioritize potential failure modes based on a chemotherapy process flowchart. Subsequently, a decision tree is used to locate potential failure modes requiring urgent improvement. Finally, some recommended actions are generated and executed to eliminate possible risks. A total of 11 failure modes were identified with high hazard scores in both inpatient and outpatient processes. Computerized physician order entry was adopted to eliminate potential risks in chemotherapy processes. Chemotherapy prescription errors significantly decreased from 3.34% to 0.40%. Chemotherapy is regarded as a high-risk process. Multiple errors can occur during ordering, preparing, compounding, dispensing, and administering medications. Subsequently, these can lead to serious consequences. HFMEA is a useful tool to evaluate potential risk in healthcare processes.

show abstract

Section: Discussionmentioning

confidence: 99%

Applying HFMEA to Prevent Chemotherapy Errors

et al. 2010

View full text Add to dashboard Cite

show abstract

“…4 Although oral chemotherapy may be more convenient than intravenous chemotherapy, it brings forth new challenges for both the patient and the care providers. 5,6 Some of these issues include: (1) safe handling, storage and disposal; (2) inability to understand complex dosing regimens; (3) novel toxicity profiles; (4) potential medication errors; (5) medication adherence; (6) accessibility and other financing issues; (7) identification and reporting of adverse drug events; and (8) anticipated and unanticipated food and drug interactions.…”

Section: Introductionmentioning

confidence: 99%

Physician–pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice

Holle

Puri

Clement

2015

J Oncol Pharm Pract

View full text Add to dashboard Cite

show abstract

“…2 His suggestions for in-house education and certification for chemotherapy administration; dose calculation by physician, pharmacist, and nurse; preprinted order sheets; dose verification procedures; elimination of acronyms and abbreviations; dose limits with panel review for higher doses; standardized prescribing vocabulary and brand names; elimination of ambiguities in drug names by drug companies; and a better informed, more inquiring patient all tend to focus on changing the processes for medication administration and the use of a collaborative approach.…”

mentioning

confidence: 99%